These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4020412)

  • 21. Doctor-patient communication about breast cancer adjuvant therapy.
    Siminoff LA; Fetting JH; Abeloff MD
    J Clin Oncol; 1989 Sep; 7(9):1192-200. PubMed ID: 2671280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials.
    Blichert-Toft M; Mouridsen H; Andersen KW
    Semin Surg Oncol; 1996; 12(1):32-8. PubMed ID: 8821407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Randomization for controlled therapeutic trials].
    Schemper M
    Wien Klin Wochenschr; 1982 Nov; 94(22):604-9. PubMed ID: 7164464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
    Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
    J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpreting physician participation in randomized clinical trials: the Physician Orientation Profile.
    Taylor KM; Kelner M
    J Health Soc Behav; 1987 Dec; 28(4):389-400. PubMed ID: 3429808
    [No Abstract]   [Full Text] [Related]  

  • 26. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.
    J Clin Oncol; 1988 Jan; 6(1):9-17. PubMed ID: 2891798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy of adult patients with soft tissue sarcomas.
    Rosenberg SA
    Important Adv Oncol; 1985; ():273-94. PubMed ID: 3916745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.
    Durie BG; Dixon DO; Carter S; Stephens R; Rivkin S; Bonnet J; Salmon SE; Dabich L; Files JC; Costanzi JJ
    J Clin Oncol; 1986 Aug; 4(8):1227-37. PubMed ID: 3525768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.
    Griem KL; Henderson IC; Gelman R; Ascoli D; Silver B; Recht A; Goodman RL; Hellman S; Harris JR
    J Clin Oncol; 1987 Oct; 5(10):1546-55. PubMed ID: 3309196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups.
    Waddell AE; Davis AM; Ahn H; Wunder JS; Blackstein ME; Bell RS
    Can J Surg; 1999 Jun; 42(3):190-9. PubMed ID: 10372015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.
    J Clin Oncol; 1988 Apr; 6(4):679-88. PubMed ID: 2895801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bias in treatment assignment in controlled clinical trials.
    Chalmers TC; Celano P; Sacks HS; Smith H
    N Engl J Med; 1983 Dec; 309(22):1358-61. PubMed ID: 6633598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.
    Eilber F; Giuliano A; Eckardt J; Patterson K; Moseley S; Goodnight J
    J Clin Oncol; 1987 Jan; 5(1):21-6. PubMed ID: 3543236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
    Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
    Carde P; Hagenbeek A; Hayat M; Monconduit M; Thomas J; Burgers MJ; Noordijk EM; Tanguy A; Meerwaldt JH; Le Fur R
    J Clin Oncol; 1993 Nov; 11(11):2258-72. PubMed ID: 7693881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.
    Fisher B; Redmond C; Wickerham DL; Bowman D; Schipper H; Wolmark N; Sass R; Fisher ER; Jochimsen P; Legault-Poisson S
    J Clin Oncol; 1989 May; 7(5):572-82. PubMed ID: 2651576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer.
    Levy S; Herberman R; Lippman M; d'Angelo T
    J Clin Oncol; 1987 Mar; 5(3):348-53. PubMed ID: 3546612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.